Results 41 to 50 of about 2,137 (167)

Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance. [PDF]

open access: yes, 2016
BackgroundDespite the effectiveness of fecal microbiota transplantation (FMT) for treating recurrent Clostridium difficile (C. difficile) infection, some patients are reluctant to accept this therapy.
Chen, Lea Ann   +7 more
core   +1 more source

Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders [PDF]

open access: yes, 2013
Industrialized society currently faces a wide range of non-infectious, immune-related pandemics. These pandemics include a variety of autoimmune, inflammatory and allergic diseases that are often associated with common environmental triggers and with ...
Adler   +133 more
core   +1 more source

Almond Polysaccharide Ameliorates DSS‐Induced Ulcerative Colitis in Mice by Restoring Intestinal Barrier Function and Modulating Gut Microbiota and SCFAs Metabolism

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
This study shows that almond polysaccharide AP1 relieves DSS‐induced UC in mice by restoring the mucosal barrier, suppressing inflammation, and modulating gut microbiota and SCFA metabolism. ABSTRACT The development of new therapeutic strategies for ulcerative colitis (UC) requires the targeting of multiple pathogenic factors, including disruption of ...
Yanqi Peng   +7 more
wiley   +1 more source

Meta-analyses of studies of the human microbiota [PDF]

open access: yes, 2013
Our body habitat-associated microbial communities are of intense research interest because of their influence on human health. Because many studies of the microbiota are based on the same bacterial 16S ribosomal RNA (rRNA) gene target, they can, in ...
Ackermann, Gail   +8 more
core   +2 more sources

Metagenomic biomarker discovery and explanation [PDF]

open access: yes, 2011
This study describes and validates a new method for metagenomic biomarker discovery by way of class comparison, tests of biological consistency and effect size estimation.
Garrett, Wendy S.   +6 more
core   +3 more sources

Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases

open access: yesAdvanced Science, Volume 12, Issue 13, April 3, 2025.
This article reviews the use of fecal microbiota transplantation (FMT) to treat intestinal diseases like recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). It discusses FMT's efficacy, influencing factors such as donor selection, recipient characteristics, and treatment protocols ...
Shuna Hou   +4 more
wiley   +1 more source

Effects of intratumoral microbiota on tumorigenesis, anti-tumor immunity, and microbe-based cancer therapy

open access: yesFrontiers in Oncology
Intratumoral microbiota (IM) has emerged as a significant component of the previously thought sterile tumor microenvironment (TME), exerting diverse functions in tumorigenesis and immune modulation.
Jingwei Zheng, Hao Chen
doaj   +1 more source

A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome : results from a randomized double-blind placebo-controlled pilot trial [PDF]

open access: yes, 2017
Background: Constipation and symptoms of gastrointestinal discomfort such as bloating are common among otherwise healthy individuals, but with significant impact on quality of life.
Marzorati, Massimo   +6 more
core   +1 more source

Disruption of the gut microbiome as a risk factor for microbial infections [PDF]

open access: yes, 2013
The discovery that microorganisms can be etiologic agents of disease has driven clinical, research and public health efforts to reduce exposure to bacteria.
Khosravi, Arya, Mazmanian, Sarkis K.
core   +1 more source

Cardiac Cachexia and the Associations to the Microbiome: State‐of‐the‐Science Review

open access: yesJCSM Communications, Volume 8, Issue 1, January/June 2025.
ABSTRACT Background Cardiac cachexia is a late manifestation of advanced heart failure, with a 5%–15% prevalence. A diagnosis of cardiac cachexia is not simply another complication of heart failure; clinical consequences of cachexia are impaired physical function, fatigue, poor quality of life and independently associated with heart failure severity ...
Kelley M. Anderson   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy